![Daniel Vasella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Vasella
Directeur/Membre du Conseil chez PEPSICO, INC.
Fortune : 11 M $ au 31/05/2025
Profil
Dr. Daniel L.
Vasella, MD, is an Independent Director at American Express Co., an Independent Director at PepsiCo, Inc., an Advisor at KBL Healthcare Ventures, a Chairman at Clade Therapeutics, Inc. and a Member-International Governors Board at The Peres Center for Peace.
He is on the Board of Directors at ImmunOs Therapeutics AG, SciClone Pharmaceuticals (Holdings) Ltd., Topadur Pharma AG, Numab Therapeutics AG, mPharma Health Nigeria Ltd., XBiotech USA, Inc., American Express Co., PepsiCo, Inc., Eclipse Bioinnovations, Inc., INSEAD and mPharma Data, Inc. Dr. Vasella was previously employed as an Independent Director by XBiotech, Inc., a Chairman by Novartis International AG, a Chairman by Novartis AG, a SVP, Chief Executive & Operating Officer by Sandoz Pharmaceuticals (UK) Ltd., a Senior VP, Chief Executive & Operating Officer by Sandoz Pharmaceuticals Corp., a Chairman by Alcon Laboratories, Inc., a Member by American Academy of Arts & Sciences, a Trustee by Carnegie Endowment for International Peace, a Vice Chairman & Chief Executive Officer by Novartis India Ltd., and a Chairman by Novartis Pharmaceuticals Corp.
He received his doctorate degree from the University of Bern.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PEPSICO, INC. 0,01 % | 01/06/2025 | 86 666 ( 0,01 % ) | 11 M $ | 31/05/2025 |
| 29/04/2025 | 0 ( -.--% ) | - $ | 31/05/2025 |
Dernières actualités sur Daniel Vasella
Postes actifs de Daniel Vasella
| Sociétés | Poste | Début |
|---|---|---|
| PEPSICO, INC. | Directeur/Membre du Conseil | 01/02/2002 |
| AMERICAN EXPRESS COMPANY | Directeur/Membre du Conseil | 20/07/2012 |
| SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED | Directeur/Membre du Conseil | 01/06/2020 |
Clade Therapeutics, Inc.
 Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Président | - |
Eclipse Bioinnovations, Inc.
 Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Topadur Pharma AG
 Topadur Pharma AG Pharmaceuticals: MajorHealth Technology Topadur Pharma AG is a patient-oriented biotech company based in Schlieren, Switzerland. Topadur focuses on enhancing the quality of life through cutting-edge research. The Swiss company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, targeting high medical needs. These compounds aim to correct locally cgmp levels, which can be the cause of several aging-related diseases resulting from insufficient local blood circulation. Topadur Pharma AG was founded in 2015 by Reto Naef, and Pascal Brenneisen has been the CEO since 2015. | Directeur/Membre du Conseil | 01/01/2020 |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG leverages its unique immune system modulating HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases. The company is based in Schlieren, Switzerland. ImmunOs’ lead program is a multi-functional HLA-fusion protein that binds specific LILRB (leukocyte immunoglobulin-like) and KIR (killer cell immunoglobulin-like) receptors and can stimulate both the innate and the adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs is also developing different modalities to agonize receptors for the modulation of the immune system in autoimmune diseases. The Swiss company was founded by Christoph Renner, Osiris Marroquin Belaunzaran. The CEO is Reinhard J. Ambros. | Directeur/Membre du Conseil | 07/06/2022 |
mPharma Data, Inc.
 mPharma Data, Inc. Packaged SoftwareTechnology Services mPharma Data, Inc. engages in the development of an application that enables physicians to prescribe and locate medicines for patients. The company is headquartered in Lexington, MA. | Directeur/Membre du Conseil | - |
mPharma Health Nigeria Ltd.
 mPharma Health Nigeria Ltd. Packaged SoftwareTechnology Services mPharma Health Nigeria Ltd. engages in the development of a pharmaceutical data management platform. The company was founded by Gregory Rockson, Dan Shoukimas and James Finucane in 2013 and is headquartered in Accra, Ghana. | Directeur/Membre du Conseil | 11/03/2019 |
| ░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Daniel Vasella
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Daniel Vasella
University of Bern | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| PEPSICO, INC. | Consumer Non-Durables |
| NOVARTIS INDIA LIMITED | Health Technology |
| NOVARTIS AG | Health Technology |
| AMERICAN EXPRESS COMPANY | Finance |
| XBIOTECH INC. | Health Technology |
| SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED | Health Technology |
| Entreprise privées | 17 |
|---|---|
Sandoz Pharmaceuticals Corp. | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
The Peres Center for Peace
 The Peres Center for Peace Miscellaneous Commercial ServicesCommercial Services The Peres Center for Peace is a non-profit, non-political, non-governmental organization focused on developing and implementing cutting edge peacebuilding programs in innovation, peace education, medicine, business, and environment. It services include training to doctors, peace education, sports, culture and the arts and technology programs. The company was founded by Shimon Peres in 1996 and is headquartered in Tel Aviv-Jaffa, Israel. | Commercial Services |
Carnegie Endowment for International Peace
 Carnegie Endowment for International Peace Miscellaneous Commercial ServicesCommercial Services Carnegie Endowment for International Peace engages in the analysis and development of policy ideas and engagement and collaboration with decision makers in the government, business, and civil society. It refers to issues such as climate and energy, defense and security, democracy and governance, economy, foreign polocy, global governance, nuclear weapons, political reform, society and culture, and technology. The company was founded by Andrew Carnegie in 1910 and is headquartered in Washington, DC. | Commercial Services |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
XBiotech USA, Inc.
 XBiotech USA, Inc. BiotechnologyHealth Technology Part of XBiotech, Inc., XBiotech USA, Inc. is a company that manufactures antibodies. The company is based in Austin, TX. The company was founded in 2005. The CEO is John Simard. | Health Technology |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
Numab Therapeutics AG
 Numab Therapeutics AG BiotechnologyHealth Technology Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Health Technology |
mPharma Health Nigeria Ltd.
mPharma Health Nigeria Ltd. Packaged SoftwareTechnology Services mPharma Health Nigeria Ltd. engages in the development of a pharmaceutical data management platform. The company was founded by Gregory Rockson, Dan Shoukimas and James Finucane in 2013 and is headquartered in Accra, Ghana. | Technology Services |
mPharma Data, Inc.
mPharma Data, Inc. Packaged SoftwareTechnology Services mPharma Data, Inc. engages in the development of an application that enables physicians to prescribe and locate medicines for patients. The company is headquartered in Lexington, MA. | Technology Services |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG leverages its unique immune system modulating HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases. The company is based in Schlieren, Switzerland. ImmunOs’ lead program is a multi-functional HLA-fusion protein that binds specific LILRB (leukocyte immunoglobulin-like) and KIR (killer cell immunoglobulin-like) receptors and can stimulate both the innate and the adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs is also developing different modalities to agonize receptors for the modulation of the immune system in autoimmune diseases. The Swiss company was founded by Christoph Renner, Osiris Marroquin Belaunzaran. The CEO is Reinhard J. Ambros. | Health Technology |
Topadur Pharma AG
Topadur Pharma AG Pharmaceuticals: MajorHealth Technology Topadur Pharma AG is a patient-oriented biotech company based in Schlieren, Switzerland. Topadur focuses on enhancing the quality of life through cutting-edge research. The Swiss company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, targeting high medical needs. These compounds aim to correct locally cgmp levels, which can be the cause of several aging-related diseases resulting from insufficient local blood circulation. Topadur Pharma AG was founded in 2015 by Reto Naef, and Pascal Brenneisen has been the CEO since 2015. | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Technology Services |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
KBL Healthcare Ventures
 KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare Ventures (KBL Healthcare) is a venture capital firm founded in 1991 by Zachary C. Berk and Marlene R. Krauss. The firm is headquartered in New York. | Finance |
